Diagnostic development using the newest technologies available to minimize cost.
Maximizing revenue and improving clinical decision making.
Medical review and sign-out for those clients who have chosen not to retain full-time clinical genetics professionals.
We work with all kind of clients who are looking for setting up laboratories.
We help diverse life sciences, clients, for implementing the latest molecular technologies. We provide a complete consulting solution providing all the details about available workflows, instruments and staffing. When it comes to starting a new molecular diagnostic or research laboratory, we can reduce the cost by 40-60%. If you are having issues with already running laboratory, we can fix the leaks and help you grow your revenue. We also provide business consulting for educating the laboratory owners to grow their business. In a nutshell we can establish a molecular laboratory based on you budget and timeline.
Experts
Industrial Callorations
Lab Partners
Established Labs
Molecular Laboratory Solutions
NGS GENETICS SOLUTION
industrial Applications
Custom solution for Lab developed tests (LDTs), we can design and validate assay for different workflows.
Designing new and innovative molecular diagnostic tests ranging from pathogenic organisms to human cancer, rare, cardiovascular, metabolic, neurodegenerative diseases.
Providing interpretation solutions for CGX, PGX, Metagenomics and animal genomics and proteomics solutions.
More than 10 years of experience in PCR/NGS Validation. Providing quality validation services according to your needs and available budget.
Reporting for CGX, PGX and other NGS panels. Fastest turnaround time without compromising on quality of analysis and reporting.
We provide consulting for pandemic preparedness by providing cutting edge tools and solutions for disease surveillance. We can help track and isolate a pathogen before it can transition from endemic to pandemic.
Our global team of scientists is continuously monitoring the emerging and spread of infectious agents. We can provide plans and technology for creating a robust Disease surveillance network to combat pathogens before they become a threat to the population.
We provide consulting for pharmaceutical clients for outsourcing R&D work. We help to cut down the cost associated with establishing state of the art R&D laboratories for clients.
Explore remote-friendly, flexible opportunities and join our mission to make work life simpler, more pleasent and more productive.
We provide custom reporting services for PCR and NGS testing.
The Raheel Biosciences Solutions Advisory Board members represent a wide array of scientific disciplines in biosciences industry and research. Their professional backgrounds include the fields of molecular diagnostics, infectious diseases, genetic markers discovery, antimicrobial stewardship, phage therapy, metagenomics and pandemic preparedness. Our Advisory Board members are industry leaders, experts and entrepreneurs who have contributed immensely in their respective fields.
Molecular diagnostics expert with extensive expertise in NGS, qPCR and In vitro diagnostic product (IVD) technologies and clinical applications. My areas of interest is setting up, operating, managing, and strengthening clinical diagnostics. In the last decade, I successfully designed and implemented very versatile IVD assays, ranging from metagenomics (infectious diseases/viral or microbiome) to human clinical/medical genomics (cancer, neurodegenerative, cardiovascular, pharmacogenomics and metabolic disorders). Working with innovative industry projects helped me to build a strong business insight to understand the ever-growing and volatile molecular diagnostic market.
I am experimental microbiologist with PhD in Virology and Immunology. I am currently working as a principal scientist at Adaptive Phage Therapeutics. I have a strong background in microbiology, virology (bacteriophage therapy) and molecular biology with solid knowledge in fundamental bacteriological approaches, also include managerial operation of the lab. My research work resulted in sixteen publications as an undergraduate, graduate and postgraduate researcher. I am self-driven and want to help advance the field of biomedical science and drug discovery.
I am currently managing an awesome team of assistant scientists while working on genetic and infectious disease testing. We test many different targets and work with multiple instruments and different workflows. I personally love and specialize in Next-generation sequencing and have worked on neuro, cancer, and pharmacogenomic panels. I am also currently enrolled in a masters program for Genomics. My personal interests surround neuroscience, pharmacology, and cannabis science. I am always eager to learn more about how the nervous system reacts and adapts to different substances. If you have any good article suggestions, please send them my way! Bachelor of Arts - Neuroscience - Rutgers University - Newark - May 2021 Master of Science - Genomics - University of Science - Philadelphia - December 2024
I am positioned among Top 2% scientists of world for the consecutive two years (2020 & 2021), by a research study conducted by Stanford University and Elsevier. I have expertise in Virology, Molecular Biology, Clinical Research, Bioinformatics and Disease Burden Estimation. I have over 160 International Research Papers including papers in world’s leading journals e.g. The Lancet, Nature, British Medical Journal and Journal of American Medical Association. My research work got over 37,000 citations in Google Scholar. I presented my research work in different countries including USA, UK, Canada, Japan, China, Netherlands, Taiwan, Brazil, South Korea and Uzbekistan. I conducted many trainings on research papers writing & publishing and research grant writing in different Universities of Pakistan.
A graduate in Biotechnology, holding PhD degree in Genomic Sciences and Biotechnology. My expertise includes genetic engineering, recombinant protein production and characterisation. Interested in development of subunit vaccines.
Dr. Sami Ullah is currently working as a product specialist (Cell line development, testing and biosafety) at Sartorius where he is giving scientific and technical consultation to clients for their recombinant proteins production needs. Although based in Germany, he is working as a specialist for Europe, Middle East, and Asia (EMEA). Dr. Sami Ullah is a PhD in Biotechnology with focus on immunology and cell models development for drug delivery studies. He is also a certified professional project manager and experienced science communicator. He has successfully used his expertise to bring success to different organizations in Germany such as the Helmholtz Association, Leibniz Association and the University Hospital of Tubingen. Dr. Sami Ullah has represented the PhD researchers from 18 different institutes of the Helmholtz association and worked as communication manager for the said organization while doing his PhD. Afterwards, he was a spokesperson for the PostDoc association of the Leibniz Association where he represented more than 5000 Scientists from 98 institutes. He was elected as an ambassador of science and worked as a science communicator, explaining science through easy experiments to college students. During the hard times of COVID-19 pandemic, he worked as diagnostics specialist apart from his regular job as a scientist at the University Hospital of Tubingen. His efforts were then recognized publicly by the city mayor and the state head of Baden Wurttemberg. Having diverse experience in immunology, cell biology, infectious diseases diagnostics and protein therapeutics, and having worked internationally on different projects, he aims to bring innovative solutions to existing problems and simplify the processes in diagnostics and therapeutics industry using his knowledge, experience and network.
Molecular Virology, Vaccine Development, Hepatitis, Hep-C, Bioinformatics, Next Generation Sequencing, Third Generation Sequencing, Immunovirology, Microbiology.
Proin iaculis purus consequat sem cure digni ssim donec porttitora entum suscipit rhoncus. Accusantium quam, ultricies eget id, aliquam eget nibh et. Maecen aliquam, risus at semper.
Export tempor illum tamen malis malis eram quae irure esse labore quem cillum quid cillum eram malis quorum velit fore eram velit sunt aliqua noster fugiat irure amet legam anim culpa.
Enim nisi quem export duis labore cillum quae magna enim sint quorum nulla quem veniam duis minim tempor labore quem eram duis noster aute amet eram fore quis sint minim.
Fugiat enim eram quae cillum dolore dolor amet nulla culpa multos export minim fugiat minim velit minim dolor enim duis veniam ipsum anim magna sunt elit fore quem dolore labore illum veniam.
Quis quorum aliqua sint quem legam fore sunt eram irure aliqua veniam tempor noster veniam enim culpa labore duis sunt culpa nulla illum cillum fugiat legam esse veniam culpa fore nisi cillum quid.
